In 2016, the Pediatric Oncology Program at C.S. Mott Children’s Hospital established a biorepository to store samples from patients seen in our clinic.
The biorepository was designed to be a robust resource for physicians and other researchers who are devoted to searching for new and improved treatments for childhood cancer.
Since its establishment, the U-M pediatric oncology biorepository has contributed to a range of projects, including:
- Developing new immunotherapy agents for pediatric AML patients
- Detecting circulating tumor cells in cerebrospinal fluid as a technique for monitoring disease in pediatric patients with CNS tumors
- Studying Ras-activating mutations in pediatric oncology patients as a method for developing therapeutic targets
For more information about pediatric oncology research at C.S. Mott Children’s Hospital, contact our clinical research coordinator or at 734-232-4046.